|
|
Volumn 58, Issue 1, 2014, Pages 98-100
|
|
Insights into the relationship between HPV/p16 status, hypoxia imaging and treatment outcomes in head and neck cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARABINOSIDE;
CETUXIMAB;
CISPLATIN;
FLUORINE 18;
FLUORODEOXYGLUCOSE;
NIMORAZOLE;
NITROIMIDAZOLE;
TIRAPAZAMINE;
ANTINEOPLASTIC AGENT;
FLUORINE;
MISONIDAZOLE;
P16 PROTEIN, HUMAN;
RADIOPHARMACEUTICAL AGENT;
TUMOR MARKER;
TUMOR PROTEIN;
CANCER RADIOTHERAPY;
CHEMORADIOTHERAPY;
DIAGNOSTIC IMAGING;
EDITORIAL;
HEAD AND NECK CANCER;
HUMAN;
HUMAN PAPILLOMAVIRUS TYPE 16;
HYPOXIA;
NONHUMAN;
ONCOLOGY;
OROPHARYNGEAL SQUAMOUS CELL CARCINOMA;
OROPHARYNX CARCINOMA;
OVERALL SURVIVAL;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RADIOSENSITIVITY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SIGNAL TRANSDUCTION;
SQUAMOUS CELL CARCINOMA;
TREATMENT OUTCOME;
ADULT;
AGED;
CELL HYPOXIA;
DIAGNOSTIC USE;
HEAD AND NECK NEOPLASMS;
MALE;
METABOLISM;
MIDDLE AGED;
PAPILLOMAVIRUS INFECTIONS;
PROCEDURES;
REPRODUCIBILITY;
SENSITIVITY AND SPECIFICITY;
STATISTICS;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
CELL HYPOXIA;
FLUORINE RADIOISOTOPES;
HEAD AND NECK NEOPLASMS;
HUMANS;
MALE;
MIDDLE AGED;
MISONIDAZOLE;
NEOPLASM PROTEINS;
PAPILLOMAVIRUS INFECTIONS;
POSITRON-EMISSION TOMOGRAPHY;
RADIOPHARMACEUTICALS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
STATISTICS AS TOPIC;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 84894086685
PISSN: 17549477
EISSN: 17549485
Source Type: Journal
DOI: 10.1111/1754-9485.12160 Document Type: Editorial |
|
Times cited : (1)
|
|
References (4)
|
